Display Settings:

Format

Send to:

Choose Destination
    Prog Clin Biol Res. 1990;337:559-65.

    Biological response modifiers (BRM), chemotherapy, and activated cytotoxic leukocyte subsets: strategies for rational design of apheresis-based cancer immunotherapies.

    Source

    National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.

    PMID:
    2353018
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk